Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Project Description:
Datamonitors' Verdezyne, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Verdezyne, Inc. since January 2007.
Scope:
– Provides intelligence on Verdezyne, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by Verdezyne, Inc. and its subsidiaries since 2007. – Information about key financial and legal advisors for Verdezyne, Inc.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Highlights:
This report includes Verdezyne, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Verdezyne, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about Verdezyne, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
300 pages •
By The Business Research Company
• Nov 2020
Oligonucleotide Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global oligonucleotide therapy market. This report focuses on oligonucleotide therapy market which is experiencing strong growth. The report...
525 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2020
Genomics is the branch of biotechnology where different techniques of genetics and molecular biology are employed to map the DNA sequences of targeted genes or the complete set of genomes of interest and then organizing the results in the database and application of data in various fields. Genomics technologies are...
Nutrigenomics Market Research Report by Product (Reagents & Kits and Services), by Application (Cancer, Cardiovascular Diseases, and Obesity) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY,...
Plant Genomics Market Research Report by Objective (DNA Extraction & Purification, DNA/Rna Sequencing, GMO-Trait Purity Testing, Gene Expression Profiling, and Genotyping), by Type (Genetic Engineering and Molecular Engineering), by Trait, by Crops - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The...
Genome Engineering Market Research Report by Technology (Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease), by Application (Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering), by End-User - Global Forecast to 2025 - Cumulative...
Global DNA Sequencing market is expected to witness a CAGR of 18.9% during the forecast period. Certain factors that are driving the market growth include the rise in technological advancements in DNA sequencing, increasing application in clinical diagnosis and drug discovery, and growing investment in R&D. The technological advancements...
The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing...
RNA Interference Technology Market Research Report by Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders, and Oncology) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP,...
The Global Genomics Partnering Terms and Agreements 2014 to 2020 report provides an understanding and access to the Genomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Genomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...